Komori
Earnings4568DAIICHI SANKYO COMPANY,LIMITEDPharmaceuticals

Summary of Consolidated Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 (IFRS)

For the interim period of the fiscal year ending March 2027, revenue, operating profit and interim profit attributable to owners of the parent exceeded the year-earlier period, with operating profit up 34.4%. The full-year earnings forecast was unchanged, while the annual dividend forecast was increased to ¥100 from ¥78 for the previous fiscal year.

Worth reading
56In focus
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
19.7
Year-on-year change in revenue (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedIFRS
Net Sales1,167,233¥ millionYear on year +19.7%Progress 49.9%
Operating profit193,795¥ millionYear on year +34.4%Progress 60.6%
Ordinary income192,855¥ millionYear on year +18.2%Progress 57.7%
Net income attributable to owners of the parent151,534¥ millionYear on year +15.8%Progress 60.4%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥83.22
Financial position at period-end
Total assets4,258,626¥ million
of which net assets 1,780,121 ¥ millionEquity ratio 41.3%vs. prior year-end -0.8pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+50,738
Investment+51,476
Financials+116,746
Net change+218,960

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥680,843 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥2,340,000 million (YoY +10.2%)
Operating profit¥320,000 million (YoY +24.0%)
Ordinary income¥334,000 million (YoY +14.2%)
Net income¥251,000 million (YoY -10.3%)
Revision to Earnings ForecastNo change
Annual Dividend Forecast¥78 /share → ¥100 /share(+28.2%)
Shareholder Return PolicyA progressive dividend policy under which adjusted DOE is maintained at 10.0% or higher each fiscal year and, in principle, dividends are maintained or increased continuously
Factors Behind Changes in Business Performance

Revenue increased due to growth in Enhertu and Datroway and the foreign exchange impact of the yen's continued depreciation. Operating profit increased due to higher revenue and the foreign exchange impact, although non-core expenses, including selling, general and administrative expenses, research and development expenses, and costs related to the reorganisation of the EU Specialty Business Unit, also increased.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 Not disclosed
Changes in the scope of consolidationMaterial changes No / New Not disclosed / Excluded Not disclosed / Company name Not disclosed
Material subsequent eventsOn 9 October 2026, the company issued its 11th through 13th series of unsecured straight corporate bonds. The total amount issued was ¥116 billion, with the proceeds to be used for working capital.
Impairment loss¥2,969 million
Depreciation and amortization¥43,351 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors, securities analysts and members of the press)
Issued Shares at Period-End1,862,893,329
Treasury Shares at Period-End40,827,459
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsIFRS
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026–30 September 2026
Net Sales¥1,167,233 million (YoY +19.7%)
Operating profit¥193,795 million (YoY +34.4%)
Ordinary income¥192,855 million (YoY +18.2%)
Profit attributable to owners of the parent¥151,534 million (YoY +15.8%)
Net income per share¥83.22
Equity ratioEnd of the current fiscal period 41.3 / End of previous period 42.1
Total assets¥4,258,626 million
Net assets¥1,780,121 million
Cash flows from operating activities¥50,738 million
Cash flows from investing activities¥51,476 million
Cash flows from financing activities¥116,746 million
Cash and cash equivalents at end of period¥680,843 million
Full-year earnings forecastNet Sales ¥2,340,000 million (YoY +10.2%) / Operating profit ¥320,000 million (YoY +24.0%) / Ordinary income ¥334,000 million (YoY +14.2%) / Net income ¥251,000 million (YoY -10.3%)
Revision to Earnings ForecastNo change
Annual Dividend Forecast¥78 /share → ¥100 /share(+28.2%)
Shareholder Return PolicyA progressive dividend policy under which adjusted DOE is maintained at 10.0% or higher each fiscal year and, in principle, dividends are maintained or increased continuously
Depreciation and amortization¥43,351 million
Impairment loss¥2,969 million
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed
Changes in the scope of consolidationMaterial changes No / New Not disclosed / Excluded Not disclosed / Company name Not disclosed
Material subsequent eventsOn 9 October 2026, the company issued its 11th through 13th series of unsecured straight corporate bonds. The total amount issued was ¥116 billion, with the proceeds to be used for working capital.
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors, securities analysts and members of the press)
Issued Shares at Period-End1,862,893,329
Treasury Shares at Period-End40,827,459
Factors Behind Changes in Business PerformanceRevenue increased due to growth in Enhertu and Datroway and the foreign exchange impact of the yen's continued depreciation. Operating profit increased due to higher revenue and the foreign exchange impact, although non-core expenses, including selling, general and administrative expenses, research and development expenses, and costs related to the reorganisation of the EU Specialty Business Unit, also increased.
Items this document does not state (7)
Operating MarginPayout ratioSegment revenueSegment profitRegional salesOrders received and order backlogBreakdown of extraordinary income (loss)

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased due to growth in Enhertu and Datroway, as well as the foreign exchange impact of the yen's continued depreciation. Operating profit benefited from higher revenue and the foreign exchange impact, while expenses such as costs related to the reorganisation of the EU Specialty Business Unit were recorded as non-core expenses.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Consolidated Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 (IFRS) | DAIICHI SANKYO COMPANY,LIMITED (4568) timely disclosure | Komori